Simone Ragusa

Simone Ragusa is a highly experienced scientist with a strong background in pharmacology, immuno-oncology, and translational research. Currently serving as a Scientist at Debiopharm since April 2022, Simone specializes in pharmacology and screening. Prior roles include Expert Scientist at Molecular Partners AG, focusing on T-cell engagers and translational research, and Laboratory Scientist at EPFL, where the emphasis was on generating autologous heterotypic 3D models for immuno-oncology programs. Simone's postdoctoral research at CHUV involved studying bispecific antibodies in chemoresistant tumors, and a PhD from the University of Lausanne was awarded for research on CRC stem cells and autophagy. Additional academic accomplishments include a Master's degree and Bachelor's degree in Medical Biotechnology from Università degli Studi di Milano.